Lunit Unveils Enhanced AI-Powered CXR Software Update

News
Article

The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.

The newly launched artificial intelligence (AI) software update Lunit Insight CXR4 may provide an array of pertinent features to facilitate smoother chest X-ray (CXR) reading for radiologists with high volume worklists.

In addition to identifying a variety of chest abnormalities, the Insight CXR4 software now provides adjunctive detection of acute bone fractures, according to Lunit, the manufacturer of the software.

Lunit Unveils Enhanced AI-Powered CXR Software Update

For radiologists in high-volume settings, the AI-enabled Lunit Insight CXR4 software update offers current-prior CXR comparison and a 99.5 percent negative predictive value (NPV) for normal CXRs, features that facilitate smoother workflow. (Image courtesy of Lunit.)

The company said the Lunit Insight CXR4 also offers comparison of current and prior CXRs, including nodule comparisons. Another key attribute of Lunit Insight CXR4 involves the flagging of normal cases. Lunit said the software, which was trained on over 1.2 million CXRs, provides a 99.5 percent negative predictive value (NPV) and generates automated reporting of normal cases.

“With Lunit Insight CXR4, we’ve gone beyond expanding detection —we’ve focused on what truly helps clinicians in their day-to-day workflow,” said Brandon Suh, the CEO of Lunit. “Features like active normal flagging and current-prior comparison are designed to reduce reading time and improve triage confidence, especially in high-volume settings.”

Lunit has achieved CE MDR certification for Lunit Insight CXR4 in Europe. As this article went to press, the software update had not been submitted for FDA 510(k) clearance, according to Lunit.

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Related Content
© 2025 MJH Life Sciences

All rights reserved.